Mumbai: PIL against antibiotics’ sale without prescription

MUMBAI: A lawyer has filed a PIL in the Bombay HC against the Union and state governments, Central Drugs Standard Control Organization (CDSCO) and drug regulator to prevent the rampant sale of high-potency antibiotics without prescription, and often over-the-counter (OTC). India is the largest consumer of antibiotics.

The petition is a result of a survey, conducted across 500 pharmacies by an NGO, which showed that antibiotics under schedule H and H1 were easily available among other OTC products. Lawyer Bharat S Kothari, in the PIL, listed concerns such as serious drug resistances and infectious diseases.

Kothari says “over 118 different formulations of fixed dose combinations were being sold in India; in UK and US, only five are sold. Of these 118, 64% were not approved by CDSCO, even though the sale of unapproved new drugs is illegal in India.”

  • Related Posts

    • Pharma
    • April 16, 2024
    • 17 views
    Rise In AMR Is Leaving Doctors With Fewer Options In Drugs

    Ahmedabad: Imagine a bacterial infection with no known cure — a relentless adversary that defies conventional treatments and leads to prolonged illness and hospitalization. This was the condition of nine people…

    • Pharma
    • April 16, 2024
    • 23 views
    CDSCO Releases Draft Guidance To Align New Drugs And Clinical Trials Rules And SUGAM For Stakeholder’s Comments

    New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has released a draft of revised Guidance for Industry document, in consultation with the stakeholders to align with the New Drugs and Clinical…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Rise In AMR Is Leaving Doctors With Fewer Options In Drugs

    Rise In AMR Is Leaving Doctors With Fewer Options In Drugs

    CDSCO Releases Draft Guidance To Align New Drugs And Clinical Trials Rules And SUGAM For Stakeholder’s Comments

    CDSCO Releases Draft Guidance To Align New Drugs And Clinical Trials Rules And SUGAM For Stakeholder’s Comments

    Glenmark recalls 6,528 bottles of BP drug in US

    Glenmark recalls 6,528 bottles of BP drug in US

    Pharma Exports To US Surges 15% In 11 Months Of FY24

    Pharma Exports To US Surges 15% In 11 Months Of FY24

    CAHO Naa Patients Se Pyaar Hai

    CAHO Naa Patients Se Pyaar Hai

    ‘Ram Kit’, Available At Many Drugstores In Agra

    ‘Ram Kit’, Available At Many Drugstores In Agra